Innovation Awards are tonight

Comments (0) Innovation Week, News

OMAHA, Neb. (Oct. 26, 2017)—Innovation Week reaches its apex tonight with the 11th annual Research Innovation Awards Banquet at 5 p.m. in the Truhlsen Campus Events Center.

The awards honor UNMC and UNO students, faculty and staff who disclosed to UNeMed a new invention, received a U.S. patent where a contributor on a licensed technology. UNeMed will also announce the 2017 Emerging Inventor of the year and the Most Promising New Invention of 2017.

The Innovation Awards is an invitation-only event. Contact UNeMed to request an invitation.

Innovation Week wraps up on Friday, Oct. 27, with a panel discussion about alternate career options for scientists.

Earlier this week, UNeMed hosted a Kick-Off event, a panel discussion about the CRISPR gene-editing tool, and an instructional worskshop on perform patent searches for biomedical research projects.

Learn more about all Innovation Week events at https://www.unemed.com/innovation-week.

Read article

Innovation Evolution: The big idea is only the beginning

Comments (0) Blog

by Charles Litton, UNeMed | October 25, 2017

Darkness often represents uncertainty. The unanswered question. The unsolved problem.

Illumination, then, reveals the unknown. Lights the path to answers. Unveils potential solutions.

It should be obvious why the light bulb has become one of the more persistent clichés on the planet. The symbolic meaning of a light bulb has entrenched itself in the public psyche as the ultimate brand for inventive creativity. It’s true that the light bulb is a cornerstone achievement for modern civilization, but that doesn’t fully explain its symbolic ubiquity.

It’s really about the light itself: the antidote for darkness.

Before Thomas Edison, the symbol was a simple flame, such as you might see flickering from a candle or oil lamp.

But look closer at Edison’s light bulb.

He tried hundreds, if not thousands, of different concepts in his quest for electric light—Different filaments, in different shapes, in different sizes and different metals, encased in different gases… The original idea turned out to be something different than what ultimately succeeded. And this was long, long after people devised flaming sticks, candles, oil lamps, gas lanterns and whatever else they used in times past to light the way.

And the journey continues today: That first light bulb looks considerably different than today’s modern LED light. What new forms—presently inconceivable—will light the darkness for us in another 100 years?

That mystery of an invention’s maturation is the very core of innovation. It’s the incremental change from the first grand idea to the thing that emerges from the development process…and then continues to evolve.

As a commercialization and technology transfer office for a major university medical school, UNeMed sees first-hand how innovations can play out like this.

Sometimes the idea is too advanced to work in the here and now.

We saw that about 10 years ago when an inventor proposed to solve the third-world’s lack of surgical access. His idea was essentially a laparoscopic tool with a camcorder stuck to the top. (Think of the ill-fated Flip Camera, which was THE go-go gadget for about 20 minutes in 2009.)

The laparoscopic invention was probably unworkable and impractical only because the idea was too advanced for the time.

Then smartphones and the iPad happened.

Now the portable laparoscope is not only entirely possible and actually feasible, it is also, dare we say, likely.

Portable Laparoscope inventor Chandrakanth Are, M.D., (right) chats with Rich Abraham of Vention Medical during a recent partnering event hosted by UNeMed earlier this year.

It might actually bring minimally invasive surgery to places where such lavish, first-world luxuries were but a dream only five years ago.

Even as the portable laparoscope relied on external technologies, most of the innovations UNeMed sees will need to run grueling marathons.

One marathon began as an unnamed discovery back in 1993. (Founded in 1991, UNeMed still had that new tech transfer office smell.)

Years later, we came to know the discovery as a synthetic peptide called EP67, and marveled at its ability to stimulate the human immune response to any number of things. Primarily, it showed promise as a way to produce vaccines for everything from the common flu to even chemical dependency.

Later, it proved to be a potent immune stimulant all by itself. The technology continued to grow and evolve as the inventor, Sam Sanderson, PhD, continued tinkering with different formulations.

Different approaches.

Different applications.

Sound familiar?

A startup company, Prommune was born from the work in the early 2000s.

A nanoformulation of the technology followed.

Then a handful of analog formulations.

And most recently, a little more than a year ago, Sanderson and Prommune were awarded about $4 million in federal grants to examine EP67’s use against dangerous infections, including methicillin resistant Staphylococcus aureus, or MRSA.

What began in 1993 was little more than an intriguing discovery with a lot of promise and hope. Just as Edison’s light bulb bears little resemblance to modern light fixtures, so too does Dr. Sanderson’s EP67 from his first discovery 25 years ago.

A lot of blood, sweat, and too many tears have passed under the bridge since then. The inventor, Dr. Sanderson, unexpectedly passed away in August.

But Prommune and EP67—and the portable laparoscope and heaps of others—live on.

And so continues the hard work of lighting the way to better health.

Late UNMC researcher Sam Sanderson, PhD, seen here during a quality control test in his Omaha lab in 2015.

Read article

Panel, workshop highlight Day 2

Comments (0) Innovation Week, News

OMAHA, Neb. (Oct. 24, 2017)—Innovation Week continued Tuesday with two educational events that looked into intellectual property issues associated with genome editing and a workshop on performing patent searches.

Channabasavaiah Gurumurthy, PhD, talks about the future of genome editing and the CRISPR/Cas9 tool during a panel discussion Tuesday at UNMC.

The day began with a panel discussion about the CRISPR/Cas9 gene-editing tool. UNMC researcher Channabasavaiah Gurumurthy, PhD, and patent attorney Bill Adolfsen, PhD, discussed potential intellectual property issues related to discoveries and innovations resulting from the CRISPR technology. They talked about how rapidly the field of gene editing has grown in just the last five years, and how much more it might evolve in the future.

Dr. Gurumurthy, the Director of the UNMC Mouse Genome Engineering Core Facility, is a co-inventor of Easi-CRISPR, a new technology that complements CRISPR’s ground-breaking ability to snip DNA. Easi-CRISPR is a proprietary protocol that allows for the easy insertion of new material into the genetic code.

Bill Adolfsen, PhD, is seen here during the panel discussion Tuesday at UNMC.

Dr. Adolfsen is a registered patent attorney and an associate at Andrus Intellectual Property Law.

Following the panel discussion, UNeMed’s Director of Intellectual Property, Jason Nickla, J.D., led a workshop to help researchers perform their own patent searches.

UNeMed offered the workshop because industry researchers don’t often publish their results in academic and scientific journals. Instead, they first publish in the form of patent applications, which won’t show up in PubMed or other academic searches.

Nickla showed attendees how hunt through various patent databases and ensure that research projects aren’t merely duplicative of previous work. He also taught specific techniques that patent examiners use to focus search hits on relevant patents.

Both events were held at the Yanney Conference Center, located on the ground floor of the Fred and Pamela Buffett Cancer Center. On Monday, UNeMed hosted a Kickoff event where staffers gave away free T-shirts, first-aid kits and other goodies.

UNMC researcher Joshua Souchek (left), PhD, works with UNeMed’s Director of Intellectual Property, Jason Nickla, J.D., during a patent searching workshop on Oct. 24, 2017.

Three events remain for Innovation Week, including a luncheon this afternoon that celebrates Nebraska women in STEM, or science, technology, engineering and math. The luncheon begins at noon at the Quarry Oaks Golf Club in Ashland, Neb.

On Thursday, Oct. 26, UNeMed will host the Research Innovation Awards Banquet in the Truhlsen Campus Events Center, located in the Michal F. Sorrell Center on the corner of 42nd and Emile Streets. The awards recognize inventive faculty, students and staff at UNO and UNMC, rewarding the achievements of those who submitted a new invention, received a U.S. patent or licensed a technology during the previous fiscal year.

A key note address will be delivered by James Linder, M.D., president of the University Technology Development Corporation and Chief Strategist for University of Nebraska President Hank Bounds. In 2014, Dr. Linder served as interim president of the University.

UNMC and UNO Chancellor Jeffrey Gold, M.D., is also expected to be on hand to present awards to inventors, including the 2017 Emerging Inventor of the year and the 2017 Most Promising New Invention.

The Awards Banquet begins at 5 p.m. and is invitation-only. Contact UNeMed to request an invitation.

Innovation Week wraps up Friday, Oct. 27, in the Yanney Conference Center at 11:30 a.m. when UNeMed hosts a panel discussion about alternate career paths for research scientists in biomedical fields.

UNeMed opened 2017 Innovation Week with its annual Kick-Off event on Monday, Oct. 23.

Panelists will include former research scientists who now work in a range of science-related fields. They are expected to discuss their personal journeys as biomedical scientists, how they arrived in their present occupations, and offer advice to others who may be interested in a science career away from the research bench.

The panelists are Amanda Hawley, PhD, Brandon Hillman, PhD, Agnes Lenagh, PhD, and Gary Madsen, PhD

The first 50 guests will receive a free lunch, and other freebies will be given away to those who ask questions and engage the panel in a meaningful way.

Learn more about all Innovation Week events at https://www.unemed.com/innovation-week.

 

Read article

How we can help: Patent searches

Comments (5) Blog

by Catherine Murari-Kanti, UNeMed | October 24, 2017

Part one of a series

The United States Patent and Trademark Office issues patents when an invention is novel, non-obvious and useful. Though these seem like straightforward requirements, a lot of work behind the scenes ensures inventions meet those criteria.

What do scientists do when they get a new idea or direction to pursue in their laboratories? They get on their computers and scour PubMed. They read, learn and comprehend the research already published. They begin to find unanswered questions.

The same line of thought goes into writing a grant proposal.

But there is one gaping hole: Many scientists fail to perform the same diligent search through existing patents or patent applications. In turn, the oversight prevents scientists from engaging in projects that are truly ground-breaking. Patent searches would help researchers find new, untapped ground.

Patent searches are part of the evaluation process at UNeMed. A member of the licensing team conducts this search to look for preexisting patents or related patent applications. If they can’t find anything, the patent potential increases.

At UNeMed, we hope to educate UNMC scientists on how to prevent duplicative research when preparing a commercialization plan in a grant. As part of our Innovation Week, UNeMed’s Director of Intellectual Property, Jason Nickla, J.D., will lead a hands-on workshop on how to run patent or patent searches. This workshop will answer some of these questions:

  • How do patent searches help your research?
  • What are the tools and databases to perform patent searches?
  • When is the right time for you to perform patent searches?

At our recently concluded Tech Transfer Boot Camp, a doctoral student said that she never knew about patent searches. Patent searches, she said, would change the way she approached new ideas and experiments in her young career.

The workshop is planned for today in the Yanney Conference Center, which is located on the ground floor of the Buffet Cancer Center. The two-hour workshop begins at 3 p.m., and is free and open to all. A light snack and refreshments will be provided. Guests are invited to bring their own laptops to practice patent searches.

This is part of a series of blog posts covering the many services UNeMed provides for faculty, students and staff at UNMC and UNO. Come for our next installment on Inventions. Here’s the full list of planned future topics:

Read article

How can we help you?

Comments (5) Blog

A few weeks ago, walking through the Sorrel Center, someone called my name. A was perfect stranger was waving his hand at me, asking if I worked at UNeMed. Then he said something that stuck with me: “Ah, UNeMed, you guys are the patent people.”

But we are so much more!

As chancellor, Dr. Jeffery Gold, has said on several occasions, research doesn’t end after publishing a paper in an academic journal or when a grant expires. Research is done when human life is changed.

At UNeMed, we want to help the University of Nebraska community convert ideas, discoveries and inventions into viable products.

Over the next several weeks, we will publish a series of blog posts that will enumerate the many ways UNeMed can help inventive UNMC and UNO faculty, students and staff. These posts will illuminate the different services provided by UNeMed and explain how we can partner with researchers, clinicians and students to improve research commercialization and patentability at the University of Nebraska.

Upcoming posts will cover:

Read article

Workshop today will instruct patent searching

Comments (0) Innovation Week, News

OMAHA, Neb. (Oct.24, 2017)—Innovation Week continues today with a two-hour workshop that will teach attendees how to perform their own patent searches, an important early step of innovative research.

Academic researchers commonly review journal articles in resources like PubMed as a way to keep abreast of scientific advances. But industry researchers don’t often publish their results in academic and scientific journals. Instead, they first publish in the form of patent applications, which won’t show up in PubMed or other academic searches.

Led by UNeMed’s Director of Intellectual Property, Jason Nickla, J.D.., the Patent Searching Workshop will show attendees how hunt through patent databases and ensure that research projects aren’t merely duplicative of previous work.

Attendees will also learn specific techniques employed by patent examiners to focus search hits on relevant patents.

The workshop is set to begin at 3 p.m. in the Yanney Conference Center, located on the ground floor of the Fred and Pamela Buffett Cancer Center. A light snack and beverages will be provided.

The workshop is part of Innovation Week, a series of events hosted by UNeMed Corporation as a celebration of the innovation and discovery that happens every year at UNMC.

Also today, UNeMed will host a panel discussion entitled “Owning CRISPR” at 1:30 p.m., also in the Yanney Conference Room.

On Thursday, UNeMed will host the 2017 Research Innovation Awards Banquet in the Truhslen Campus Events Center in the Michael F. Sorrell Center at 5 p.m. Contact UNeMed to request an invitation.

Innovation Week wraps up on Friday, Oct. 27, with another panel discussion, this one about alternate career options for scientists.

Learn more about all Innovation Week events at https://www.unemed.com/innovation-week.

Read article

Panel will discuss the CRISPR gene editing tool

Comments (0) Innovation Week, News

OMAHA, Neb. (Oct.24, 2017)—Innovation Week continues today with a panel discussion about the biomedical applications and implications of the CRISPR/Cas9 gene editing tool.

Panelists will include UNMC researcher Channabasavaiah Gurumurthy, PhD, and patent attorney Bill Adolfsen, PhD They are expected to discuss potential intellectual property issues related to discoveries and innovations resulting from the CRISPR technology.

The CRISPR event is set to begin at 1:30 p.m. in the Yanney Conference Center located on the ground floor of the Fred and Pamela Buffett Cancer Center.

Dr. Gurumurthy

Dr. Adolfsen

Dr. Gurumurthy is the Director of the UNMC Mouse Genome Engineering Core Facility, and also carries an Executive MBA degree from the University of Nebraska at Omaha. Most recently, he is a co-inventor of Easi-CRISPR, a new technology that complements CRISPR’s ground-breaking ability to snip DNA. Easi-CRISPR is a proprietary protocol that allow for the easy insertion of new material into the genetic code.

Dr. Adolfsen is a registered patent attorney and associate at Andrus Intellectual Property Law.  He focuses his practice on domestic and international patent prosecution, strategic patent portfolio development, post-grant proceedings, and enforcement.  He also provides counseling related to patentability, freedom-to-operate, non-infringement, and patent validity. He received his doctorate in molecular biology from MIT in 2005, and a juris doctor degree from the University of Wisconsin Law School in 2013.

The panel discussion is part of Innovation Week, a series of events hosted by UNeMed Corporation as a celebration of the innovation and discovery that happens every year at UNMC.

Also today, UNeMed will host a Patent Searching Workshop at 3-5 p.m. in the Yanney Conference Room.

On Thursday, UNeMed will host the 2017 Research Innovation Awards Banquet in the Truhslen Campus Events Center in the Michael F. Sorrell Center at 5 p.m. Contact UNeMed to request an invitation.

Innovation Week wraps up on Friday, Oct. 27, with another panel discussion, this one about alternate career options for scientists.

Learn more about all Innovation Week events at https://www.unemed.com/innovation-week.

Read article

UNeMed releases 2017 annual report

Comments (0) News

OMAHA, Neb. (Oct. 23, 2017)—UNeMed released today its 2017 annual report for the fiscal calendar year.

The report details UNeMed’s key metrics, and highlights notable achievements during the previous fiscal year.

In an overview, the report notes the long journey of innovation, particularly in biomedical fields. The report cites several examples of innovations that evolve and grow as inventors continue to build on an idea. Often, the final product looks remarkably different than the original idea. The report also highlights several “featured current technologies” before diving into metrics from the previous fiscal year.

Among the more noteworthy metrics from 2017 is the number of agreements. In 2017 UNeMed set another new company record for material transfer agreements. UNeMed signed 366 MTAs, the 12th straight year setting a record in that category.

UNeMed also signed an all-time high 23 licensing deals in in 2017. The previous record was 22, set in 2013.

There were also marked increases in patents and revenue. UNeMed’s 52 issued patents was a 108 percent increase over the previous fiscal year. UNeMed brought in $2.27 million to the University of Nebraska, which was 31 percent increase and the third-highest tally in UNeMed’s 26-year history.

The report can be viewed online, but printed copies are also available. Contact UNeMed to receive a free printed copy.

2017 Annual Report by UNeMed Corporation on Scribd

Read article

Innovation Week kicks off today

Comments (0) Innovation Week, News

OMAHA, Neb. (Oct. 23, 2017)—Innovation Week kicks-off today in the Durham Research Center atrium at 9-11 a.m.

The Kick-Off will feature free pens, T-shirts and a chance to mingle with UNeMed staff. Jo-on-the-Go will also be on hand, providing complimentary espressos and smoothies to all attendees.

Innovation Week is a series of events hosted by UNeMed to celebrate and honor the innovations and discoveries at UNMC each year.

Innovation Week continues Tuesday, Oct. 24, with a panel discussion about the biomedical applications and implications of the CRISPR/Cas9 gene editing tool. Panelists will include UNMC researcher Channabasavaiah Gurumurthy, PhD, and patent attorney Bill Adolfsen, PhD That event is set to begin at 1:30 p.m. in the Yanney Conference Center located on the ground floor of the Fred and Pamela Buffett Cancer Center.

Also Wednesday in Yanney Conference Center, UNeMed’s Director of Intellectual Property, Jason Nickla, J.D., will lead a hands-on workshop on how to run patent searches. The workshop is planned from 3-5 p.m. A light snack and refreshments will be provided.

Innovation Week continues Wednesday, Oct. 25, when BioNebraska hosts a luncheon and networking session celebrating “Nebraska Women in science, technology, engineering and math.” The luncheon will be at the Quarry Oaks Golf Club in Ashland, Neb., at noon=-2 p.m. Cost per ticket is $25. Contact Phil Kozera at pkozera@bionebraska.org or 308-440-8828 to RSVP.

Innovation Week’s main event is on Thursday, Oct. 26, when UNeMed hosts the Research Innovation Awards Banquet. The ceremony will recognize all those who were issued a new patent, licensed a technology, or developed a new invention over the previous year. UNeMed will also present special awards for the “Most Promising New Invention” of 2017 and the “Emerging Inventor.” The Awards will be at the Michael F. Sorrell Center in the Truhlsen Campus Events Center beginning at 5 p.m. Contact UNeMed to request an invitation.

Finally, Innovation Week concludes Friday, Oct. 27, with a panel discussion about alternate career options for scientists away from the bench. The panel will also meet in the Yanney Conference Center, beginning at 11:30 a.m. Free lunch will be provided to the first 50 guests.

Learn more about all Innovation Week events at https://www.unemed.com/innovation-week.

Read article

Three seminars planned for I-Week

Comments (0) Innovation Week, News

OMAHA, Neb. (Oct. 20, 2017)—Three educational opportunities will be presented during Innovation Week, officials announced today.

Innovation Week is a series of events hosted by UNeMed to celebrate and honor the innovations and discoveries at UNMC each year. UNeMed—the technology transfer and commercialization office for the University of Nebraska’s Omaha campuses—will host the events. All are free and open to everyone.

The events are a two-person panel on the development and protection of a controversial new gene-editing tool called CRISPR; a learning workshop on conducting patent searches; and a four-person panel discussion about alternate science careers away from the research bench.

On Tuesday, Oct. 24, “Owning CRISPR” is expected to focus on the biomedical applications and implications of the CRISPR/Cas9 gene editing tool. Panelists will include UNMC researcher Channabasavaiah Gurumurthy, PhD, and patent attorney Bill Adolfsen, PhD That event is set to begin at 1:30 p.m. in the Yanney Conference Center located on the ground floor of the Fred and Pamela Buffett Cancer Center.

Also Wednesday in Yanney Conference Center, UNeMed’s Director of Intellectual Property, Jason Nickla, J.D., will lead a hands-on workshop on how to run patent searches. The workshop is planned from 3-5 p.m. A light snack and refreshments will be provided.

Finally, on Friday, Oct. 27, a panel will discuss alternate career options for scientists away from the bench. The panel will also meet in the Yanney Conference Center, beginning at 11:30 a.m. Free lunch will be provided to the first 50 guests.

Other innovation Week events include a Kickoff event, a luncheon celebrating women in STEM fields and an Awards banquet.

The Kick-Off will feature free pens, T-shirts and a chance to mingle with UNeMed staff. Jo-on-the-Go will also be on hand, providing complimentary espressos and smoothies to all attendees. That will be held in the Durham Research Center atrium at 9-11 a.m.

Innovation Week continues Wednesday, Oct. 25, when BioNebraska hosts a luncheon and networking session celebrating “Nebraska Women in science, technology, engineering and math.” The luncheon will be at the Quarry Oaks Golf Club in Ashland, Neb., at noon-2 p.m. Cost per ticket is $25. Contact Phil Kozera at pkozera@bionebraska.org or 308-440-8828 to RSVP.

Innovation Week’s main event is on Thursday, Oct. 26, when UNeMed hosts the Research Innovation Awards Banquet. The ceremony will recognize all those who were issued a new patent, licensed a technology, or developed a new invention over the previous year. UNeMed will also present special awards for the “Most Promising New Invention” of 2017 and the “Emerging Inventor.” The Awards will be at the Michael F. Sorrell Center in the Truhlsen Campus Events Center beginning at 5 p.m. Contact UNeMed to request an invitation.

Learn more about all Innovation Week events at https://www.unemed.com/innovation-week.

Read article

Innovation Week starts Monday

Comments (0) Innovation Week, News

OMAHA, Neb. (Oct. 20, 2017)—The 11th annual Innovation Week kicks off Monday, Oct. 23, to celebrate and recognize world-class research and discovery at the University of Nebraska Medical Center and the University of Nebraska at Omaha.

Hosted by UNMC’s and UNO’s technology transfer and commercialization office, UNeMed Corporation, Innovation Week begins with an open house 9 a.m. Monday, Oct. 23, in the Durham Research Center atrium. The week culminates with the UNMC Research Innovation Awards Banquet Thursday, Oct. 26.

All events are free and open to the public, but the Awards Banquet is an invitation-only event. Further details can be found on the Innovation Week page.

Following Monday’s Kick-off event, Innovation Week continues the following day with a panel discussion about the biomedical applications and implications of the CRISPR/Cas9 gene editing tool. Panelists will include UNMC researcher Channabasavaiah Gurumurthy, PhD, and patent attorney Bill Adolfsen, PhD They are expected to discuss potential intellectual property issues related to discoveries and innovations resulting from the CRISPR technology.

The CRISPR event is set to begin at 1:30 p.m. in the Yanney Conference Center located on the ground floor of the Fred and Pamela Buffett Cancer Center.

Also Wednesday in the Yanney Conference Center, UNeMed’s Director of Intellectual Property, Jason Nickla, J.D., will lead a hands-on workshop on how to run patent searches. The workshop is planned from 3-5 p.m. A light snack and refreshments will be provided.

Innovation Week continues Wednesday, Oct. 25, when BioNebraska hosts a luncheon and networking session celebrating “Nebraska Women in science, technology, engineering and math.” The luncheon will be at the Quarry Oaks Golf Club in Ashland, Neb., at noon-2 p.m. Cost per ticket is $25. Contact Phil Kozera at pkozera@bionebraska.org or 308-440-8828 to RSVP.

Innovation Week’s main event is on Thursday, Oct. 26, when UNeMed hosts the Research Innovation Awards Banquet. The ceremony will recognize all those who were issued a new patent, licensed a technology, or developed a new invention over the previous year. UNeMed will also present special awards for the “Most Promising New Invention” of 2017 and the “Emerging Inventor.” The Awards will be at the Michael F. Sorrell Center in the Truhlsen Campus Events Center beginning at 5 p.m. Contact UNeMed to request an invitation.

Finally, Innovation Week concludes Friday, Oct. 27, with a panel discussion about alternate career options for scientists away from the bench. The panel will also meet in the Yanney Conference Center, beginning at 11:30 a.m. Free lunch will be provided to the first 50 guests.

More details about individual events will be available soon, and announced through UNeMed’s Facebook page and Twitter feed.

 

Read article

UNeTech signs first four startup companies

Comments (2) News

by Vicky Cerino, UNMC

UNeTech, a new institute at the University of Nebraska Medical Center and University of Nebraska at Omaha designed to identify promising startup companies and help them become successful, has identified its first four startup companies.

The companies, which will be housed in the UNeTech building at 3929 Harney St., are:

  • FutureAssure – Built around the research of Jason Johanning, M.D., a UNMC vascular surgeon, the company uses new devices and software to assess patient frailty. Research has shown frailty is an effective way to assess likely outcomes of surgery. FutureAssure combines the best available methods to assess frailty with a new medical instrument. The company’s approach captures and assesses the information automatically which saves time and money.
  • Peston Badeer

    Preston Badeer

    Avert – Developed by Preston Badeer, a community entrepreneur, the company has developed a program that can determine if someone has sustained a concussion or has recovered from a concussion by analyzing the individual’s balance. The company originated in the Biomechanics Research Building at UNO. Avert is looking for strategic partners to deploy its proprietary software.

  • Esculon – Developed by community entrepreneur Evan Luxon, the company is designing a chest tube that doesn’t clog. Chest tubes are used to help drain air, blood or fluid from the space surrounding the lungs following surgery. After placement by the surgeon, the biggest complication of chest tubes is blockage. Esculon is making a self-irrigating chest tube that is less likely to clog.
  • Virtual Cardiovascular Solutions – A product of collaboration between Ed O’Leary, M.D., UNMC cardiologist and Hani Haider, PhD, an orthopedic researcher. They provide cutting edge educational tools to improve a wide range of medical knowledge and skills such as AngioTeacher, the first interactive medical educational software application designed to help students learn to interpret coronary angiograms through a three-dimensional computed tomographic angiographic model of the heart.
Rodney Markin - Pathology

Rodney Markin

Rod Markin, M.D., PhD, executive director of UNeTech, said the company will raise between $7 and $10 million to help promising technology and start-up companies during their first few years, also known as the “Valley of Death,” when half of new businesses fail.

Joe Runge, J.D., associate director of UNeTech, said UNeTech is not a venture capital fund, but a cluster of expertise focused on the health care field.

“We’re creating products people really need to improve access to health care and contribute to the financial benefit for the university as well,” Runge said. “UNeTech benefits UNMC by exposing our faculty to a whole different type of research that helps start-ups answer questions and problems.

“UNeTech serves as an incubator that can curate a very particular set of clinicians and researchers to help address problems faced by start-ups. We combine lessons — as well as what is unique to Omaha and especially to Nebraska — which will make us successful.”

Some of UNeTech’s broad mandate is leveraging relationships to find opportunities of value to advance technology from a start-up. “We look at it as an investment and what we expect the return to be – using the same analysis an investment company would use,” Runge said.

Over time, the building could accommodate as many as 10-12 start-up companies.

Read article

‘Confessions of a Venture Capitalist’ planned for Sept. 12

Comments (0) News

OMAHA, Nebraska (August 30, 2017)—The University of Nebraska and Pipeline Entrepreneurs, a regional entrepreneurial organization, will offer the public a rare opportunity to peek inside the mind of venture capitalists next month.

Set for Tuesday, Sept. 12, “Confessions of a Venture Capitalist” will feature a moderated and open conversation that should reveal all that seasoned investors seek in small businesses and startups.

The event will be in the Mammel Hall Auditorium at the University of Nebraska at Omaha at 4:30 p.m. Refreshments and light snacks will be provided.

James Linder, M.D.—former interim President and current Chief Strategist for the University of Nebraska—will moderate the discussion.

“This is going to be a really great opportunity for our students and the local start-up community,” Linder said. “Securing angel or venture funding is essential for new enterprises, and our two guests will offer rare insight into their decision process.”

Kilcrease

The event will feature Laura Kilcrease and Niall O’Donnell. Both are mentors at Pipeline, an entrepreneurial fellowship that focuses on nurturing Nebraska, Kansas and Missouri entrepreneurs and their businesses.

Kilcrease is the CEO of Alberta Innovates and founder and managing director of Triton Ventures, a venture capital fund investing in early-stage technology companies.

O’Donnell is a managing director at RiverVest Venture Partners, a venture capital firm focused on life science startups and companies.

Dr. O’Donnell

“Confessions of a Venture Capitalist” is sponsored by UNO’s Center for Innovation, Entrepreneurship and Franchising and UNMC’s technology transfer office, UNeMed.

The event is free and open to all. To RSVP, go to https://pipelineconfessionsofavc.eventbrite.com/.

Read article

Boot Camp 2017: Student becomes teacher

Comments (0) Blog

by Catherine Murari-Kanti, UNeMed | Aug. 30, 2017

In 2015, I participated in UNeMed’s first ever Boot Camp. In 2017 it was my turn to organize and conduct the very thing that began my career.

In 2015, I was finishing up my doctorate, and I knew that I didn’t want an academic career. Prior to that, I participated in UNeMed’s Research Commercialization course, and realized that I enjoyed the concept of taking science from the bench to the market.

The Boot Camp was an eye-opening experience that allowed me to learn, grow and seek out opportunities to work in a technology transfer office. I applied and was interviewed for internships at other technology transfer offices. Most of my interviewers were surprised with the tech transfer knowledge I had during the interview.

Eventually, that led to an internship, followed by my current position at UNeMed. Then I was asked to take the lead for this year’s Boot Camp. We had an eclectic mix of 14 participants that included graduate students, post-doctoral students, medical students, a practicing physician and industry professionals. Most of them had minimal to zero working knowledge of a technology transfer office such as UNeMed.

UNeMed staffers instructed participants on a variety of technology transfer topics. Students were expected to evaluate the new inventions, conduct prior art searches, analyze markets and write non-confidential marketing materials and negotiate contracts. On the last day of Boot Camp, participants presented their evaluations to UNeMed staff. It is the hope that this short, hands-on, interactive training camp prepares the participants for an eventual career in technology transfer.

Medical students enrolled in the Enhanced Medical Education Track expressed interest in understanding the nuances of prior art searches and the IP landscape. One of the post docs from Creighton University, Razia Aziz-Seible, was intrigued by the “valley of death:” The place where most technologies go to die because of a lack of funding.  Aziz-Seible asked a lot of questions on what researchers like her to could do to prevent innovation death.

“Even though this Boot Camp seemed to be intended for those in the academic realm, it was entirely beneficial for those in industry,” said Nicholas George, a Senior Research Scientist at Streck Incorporated, a local biotech company.

For me, it was an intense week of passing along knowledge that can be used wherever their journeys take them. I enjoyed interacting with them, getting to know their stories, struggles and victories, and I am thankful that they can add this to their quiver as they march along their path of scientific research.

The Boot Camp aligns with UNeMed’s educational mission in providing an opportunity for growth and learning and fostering a culture of innovation at UNMC. Every year students, and sometimes faculty, participate in a week-long exercise of understanding and learning the different aspects of commercializing science. The topics covered during the Boot Camp include the evaluation of new inventions, intellectual property law, technology marketing and commercialization and contract negotiation.

Read article

Prommune’s swine flu vaccine succeeds in latest animal trial

Comments (0) News, Success Stories

Sam Al-Murrani

Sam Al-Murrani, PhD, interim CEO of Prommune, addresses the audience during UNeMed’s 2016 Demo Day.

KANSAS CITY, Mo. (Aug. 24, 2017)—Prommune Inc., a Midwest-based developer of advanced biologics, announced the completion of its third proof of concept study in pigs.

The latest study related to its lead products HeptaVac™, a self-adjuvating peptide vaccine cocktail and HISP-P™, an immunoactivator and molecular adjuvant both for use in pigs with Swine Influenza A Virus infections.

HeptaVac™ was designed to elicit cellular immunity and contains antigenic peptides from the H1N1 influenza virus proteins, two of which represent conserved sequences between the seasonal and pandemic strains. Each antigenic peptide was individually linked to Prommune’s molecular adjuvant HISP™ which activates the innate immune system and generates a Th1-biased immune response. HeptaVac™ was delivered intramuscularly and showed a dose response and a statistically significant reduction in the number of lung lesions in pigs infected with the H1N1 strain of the virus compared to the controls.

Another arm of the study compared the efficacy of HeptaVac™ to HISP-P™ delivered intranasally. This part of the study again showed the efficacy of HeptaVac™ but also showed that the immunoactivator HISP-P™ can reduce the viral load in lung lesions in a statistically significant manner in addition to an overall reduction in the number of lesions. Successful intranasal delivery, opens the door for potential use as mucosal vaccines and adjuvants.

Prommune has recently engaged a cGMP manufacturing partner and will be initiating filings to obtain the necessary licenses to market the two products in the US, in the coming weeks. It is also continuing its research and development activities on its pipeline of products for other production animal species and expects to apply for further licenses within the next 12-18 months.

UNMC researcher Sam Sanderson, PhD, who unexpectedly passed away on Aug. 7, 2017, founded Prommune about a decade ago.

Dr. Sam Al-Murrani, interim CEO added, “There is a considerable need for new therapeutics, prophylactics and adjuvants for veterinary and human medicine applications. Prommune’s lead biologics engage and activate the immune system in ways that are different from the ways through which the majority of “classical” vaccines and adjuvants currently work.”

Prommune is positioning itself at the forefront of next generation biologics developers with a pipeline of innovative products each designed to fill the need for new modalities to combat existing and emerging zoonotic diseases.

Prommune is a UNMC startup built on the research of the late Sam Sanderson, Ph.D.

For further information, please contact Prommune Inc. at info@prommuneinc.net or call toll free 877-426-9009.

Read article

UNMC’s glaucoma breakthrough featured in journal ‘Stem Cells’

Comments (0) News

Findings could lead to early diagnosis, new treatment therapies

by Lisa Spellman, UNMC

A University of Nebraska Medical Center researcher has discovered that a common form of glaucoma that strikes adults may have early origin. The discovery, which is detailed in the August 9 issue of the journals Stem Cells, could result in earlier diagnosis and treatment of the disease that is the second leading cause of irreversible blindness and affects more than 3 million people in the United States and 60 million people worldwide.

Iqbal Ahmad, PhD, a professor in the department of ophthalmology and visual sciences at UNMC, led the team of investigators. He has spent more than a decade studying the stem cell approach to understand and treat glaucoma, which is called a silent robber of vision because it strikes without warning or any noticeable symptoms.

“There are several forms of glaucoma but all have two things in common – the progressive degeneration of retinal ganglion cells (RGCs) and the irreversible loss of vision,” Dr. Ahmad said.

The primary function of RGCs is to tell the brain through a series of synapses and connections what the eye sees, he said. Without RGCs, there is no perception of vision.

Since glaucoma is generally a late onset disease and RGCs are formed during gestation, Dr. Ahmad’s team had to find a way to study the degeneration process, which they hypothesized was because of a developmental abnormality.

Using blood from patients carrying a specific gene variation and also suffering from primary open angle glaucoma (POAG), one of the more common forms of the disease, Dr. Ahmad and his team created a pluripotent stem cell-based model of POAG to understand why and how  RGCs degenerate.

Dr. Ahmad’s team was able to show that RGCs from POAG patients were different from those generated from healthy donors.

“They were developmentally abnormal in form, function and gene expression,” he said, adding that knowing the molecular basis of the defect and its biomarkers will allow early diagnosis and treatment.

“We are excited, as it is an important first step toward early diagnosis and treatment of this debilitating disease,” Dr. Ahmad said.

Shane Haven, M.D., a glaucoma specialist at UNMC’s Truhlsen Eye Institute, said, “Dr. Ahmad’s work could help us better understand the pathophysiology of degenerative conditions and in turn, reveal new treatment targets and cell replacement therapies.”

Read article